FDA Import Refusal SCS-5846869-2/10002/1 — Dexlevo Inc
The FDA refused shipment SCS-5846869-2/10002/1 from Dexlevo Inc (South Korea) on Jul 24, 2026. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 471,475 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Jul 24, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 66VIK99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 471,475